Manufacturer record
Ikon Pharmachem Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Ikon Pharmachem Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between November 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T252024, Sodium Bicarbonate Tablet USP 500 mg (exp Oct 2027). DTL, Delhi (state lab) found it not of standard quality: Test For Assay (Content) Of Sodium Bicarbonate. Listed in the August 2026 alert.
Records by type
3 records linked to Ikon Pharmachem Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sodium Bicarbonate Tablet USP 500 mg | Batch T252024Mfg Nov 2025 · Exp Oct 2027 | Test For Assay (Content) Of Sodium BicarbonateAssay | DTL, DelhiState lab | Aug 2026 |
| Bethanechol Chloride Tablets USP 25mg | Batch T251976Mfg Oct 2025 · Exp Sep 2027 | The sample does not conform to the USP with respect to Assay.Assay | DTL JaipurState lab | May 2026 |
| Clopidogrel & Aspirin Tablets | Batch T250139Mfg Jan 2025 · Exp Dec 2026 | The sample does not conform to IP Standards with respect to Dissolution, Related Substances and Assay of Aspirin Standards.Assay | DTL ThrissurState lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.